PNP THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 1
- Market Cap
- -
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Phase 1
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Genetic: Ad/PNP and fludarabine monophosphate
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- PNP Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01310179
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath